View Author
Schraffordt Koops, H.
( H. Schraffordt Koops)
patient cancer tumor necrosis model resection sarcoma teratoma probability study perfusion chemotherapy tissue value predictor level limb perfusion histology prechemotherapy treatment 130.115.129.41. copyright 1995 library erasmus mc tissue sarcomas extremity table response melphalan result score tumor necrosis factor toxicity schraffordt koops h american society grade oncol postchemotherapy shrinkage center regression testicular masse therapy factor analysis tissue sarcoma oncology multivariate surgery nonseminomatou effect marker 186 patients melanoma prechemotherapy ldh level amputation recurrence prognostic score chart prognostic radiation radiation therapy erasmu eggermont metastatic multivariate models discriminative ability information american society rotterdam month variable postchemotherapy mass size testicular cancer tumor histology presize antitumor effects group extremity sts retroperitoneal preoperative
2 Most Recent Publications
|
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience
(Article)
Eggermont, A.M.M. Schlag, P.M. Kettelhack, C. Schraffordt Koops, H. Klausner, J.M. Kroon, B.B. Lienard, D. Geel, A.N. van Lejeune, F.J. Hoekstra, H.J. Meller, I. Pector, J.C. Nieweg, O.E. Ben-Ari, G. |
1996-01-01
|
|
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
(Article)
Steyerberg, E.W. Keizer, H.J. Fossa, S.D. Sleijfer, D.T. Toner, G.C. Schraffordt Koops, H. Mulders, P.F. Ney, K. Donohue, J.P. |
1995-05-01
|
